Immunocore Holdings (IMCR) Non-Current Assets (2019 - 2026)

Immunocore Holdings (IMCR) has reported Non-Current Assets for 8 consecutive years, with $68.3 million the latest figure, recorded in Q1 2026.

• Quarterly Non-Current Assets fell 13.98% year-over-year to $68.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $307.4 million (up 5.07% YoY) and the FY2025 annual result came in at $62.1 million, up 11.09% from the prior year.
• Non-Current Assets rose to $68.3 million in Q1 2026 per IMCR's latest filing, from $62.1 million in the prior quarter.
• Over the last five years, Non-Current Assets for IMCR reached as high as $80.1 million in Q2 2025 and fell as low as $48.5 million in Q3 2022.
• A 5-year average of $65.4 million and a median of $66.5 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2025 — Non-Current Assets rose 20.42% — and 2026, when it slipped 13.98%.
• Year by year, Non-Current Assets stood at $51.2 million in 2022, then advanced by 8.24% to $55.4 million in 2023, then rose by 0.9% to $55.9 million in 2024, then grew by 11.09% to $62.1 million in 2025, then grew by 9.96% to $68.3 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $68.3 million, $62.1 million, and $79.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.